• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74].

作者信息

Sato Koichi, Akamatsu Hiroaki, Murakami Eriko, Sasaki Seigo, Kanai Kuninobu, Hayata Atsushi, Tokudome Nahomi, Akamatsu Keiichiro, Koh Yasuhiro, Ueda Hiroki, Nakanishi Masanori, Yamamoto Nobuyuki

机构信息

Third Department of Internal Medicine, Wakayama Medical University, Japan.

Third Department of Internal Medicine, Wakayama Medical University, Japan.

出版信息

Lung Cancer. 2018 Dec;126:230-231. doi: 10.1016/j.lungcan.2018.11.007. Epub 2018 Nov 18.

DOI:10.1016/j.lungcan.2018.11.007
PMID:30459086
Abstract
摘要

相似文献

1
Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74].《“纳武利尤单抗治疗非小细胞肺癌中免疫相关不良事件与疗效的相关性”的勘误》[《肺癌》115卷（2018年）第71 - 74页]
Lung Cancer. 2018 Dec;126:230-231. doi: 10.1016/j.lungcan.2018.11.007. Epub 2018 Nov 18.
2
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab.纳武利尤单抗治疗非小细胞肺癌的免疫相关不良事件与疗效的相关性。
Lung Cancer. 2018 Jan;115:71-74. doi: 10.1016/j.lungcan.2017.11.019. Epub 2017 Nov 21.
3
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.免疫相关不良事件对纳武利尤单抗治疗的晚期非小细胞肺癌患者生存的影响：多机构分析的长期结果。
J Cancer Res Clin Oncol. 2019 Feb;145(2):479-485. doi: 10.1007/s00432-018-2805-3. Epub 2018 Dec 1.
4
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.纳武利尤单抗用于治疗晚期鳞状非小细胞肺癌的不吸烟者：来自意大利扩大可及项目队列的结果
Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047.
5
Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.纳武利尤单抗治疗晚期非小细胞肺癌的真实世界疗效和安全性：一项回顾性多中心分析。
Clin Lung Cancer. 2018 May;19(3):e349-e358. doi: 10.1016/j.cllc.2018.01.001. Epub 2018 Jan 5.
6
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.尼伏单抗相关胆管炎在非小细胞肺癌患者的影像学和临床病理特征。
Invest New Drugs. 2017 Aug;35(4):529-536. doi: 10.1007/s10637-017-0453-0. Epub 2017 Mar 20.
7
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.纳武利尤单抗治疗晚期非小细胞肺癌日本患者的早期死亡分析。
Clin Lung Cancer. 2018 Mar;19(2):e171-e176. doi: 10.1016/j.cllc.2017.09.002. Epub 2017 Oct 13.
8
The safety of nivolumab for the treatment of advanced non-small cell lung cancer.纳武单抗治疗晚期非小细胞肺癌的安全性。
Expert Opin Drug Saf. 2017 Jan;16(1):101-109. doi: 10.1080/14740338.2017.1267725. Epub 2016 Dec 11.
9
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.纳武单抗治疗轻度特发性间质性肺炎的晚期非小细胞肺癌患者的一项试点试验。
Lung Cancer. 2017 Sep;111:1-5. doi: 10.1016/j.lungcan.2017.06.008. Epub 2017 Jun 17.
10
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study.纳武利尤单抗治疗晚期非小细胞肺癌患者的早期免疫相关不良事件与结局的相关性：一项前瞻性队列研究。
J Thorac Oncol. 2017 Dec;12(12):1798-1805. doi: 10.1016/j.jtho.2017.08.022. Epub 2017 Sep 20.

引用本文的文献

1
Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer.程序性死亡蛋白1/程序性死亡配体1抑制剂诱发的晚期肺癌甲状腺功能障碍
Heliyon. 2024 Feb 24;10(5):e27077. doi: 10.1016/j.heliyon.2024.e27077. eCollection 2024 Mar 15.
2
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.接受纳武利尤单抗治疗的非小细胞肺癌患者血清游离 T4 水平降低的临床影响。
Sci Rep. 2019 Nov 19;9(1):17085. doi: 10.1038/s41598-019-53327-7.
3
Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.
尼伏单抗导致的甲状腺功能紊乱：探寻疾病模式和结果。
Endocrine. 2019 Jun;64(3):605-613. doi: 10.1007/s12020-019-01871-7. Epub 2019 Feb 25.